BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 45 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 45 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
Market News

Earnings Summary: CME Group reports flat Q3 adj. earnings; revenue dips

CME Group Inc. (NASDAQ: CME), which operates derivatives exchanges, on Wednesday reported financial results for the third quarter of fiscal 2025. The company reported Q3 revenue of $1.54 billion, vs. $1.58 billion in the year-ago quarter Clearing and Transaction Fees revenue totaled $1.2 billion in Q3; Market Data revenue totaled a record $203 million Operating income was […]

October 22, 2025 1 min read

CME Group Inc. (NASDAQ: CME), which operates derivatives exchanges, on Wednesday reported financial results for the third quarter of fiscal 2025.

  • The company reported Q3 revenue of $1.54 billion, vs. $1.58 billion in the year-ago quarter
  • Clearing and Transaction Fees revenue totaled $1.2 billion in Q3; Market Data revenue totaled a record $203 million
  • Operating income was $973 million in the third quarter, compared to $1.02 billion in Q3 2024
  • Net income declined to $908 million or $2.49 per share from $912.8 million or $0.50 per share last year
  • Adjusted net income was $1.0 billion or $2.68 per share in Q3, broadly unchanged from the prior-year quarter
  • In the first nine months of the year, the company paid dividends of around $3.5 billion
  • It has returned over $29.5 billion to shareholders in the form of dividends since early 2012
ADVERTISEMENT